Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Hurd

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|May 7, 1999
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal diseaseJ J Perry, R A Fleming, M V Rocco, et al.
Haematology and Blood Transfusion|January 1, 1985
Chromosome abnormalities in malignant lymphoma: biologic and clinical correlationsC D Bloomfield, D C Arthur, E G Levine, et al.
Genes, Chromosomes & Cancer|March 1, 1990
Sequential karyotypes in non-Hodgkin lymphoma: their nature and significanceE G Levine, S Juneja, D Arthur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host diseaseD J Weisdorf, M E Nesbit, N K Ramsay, et al.
Blood|November 1, 1988
Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remissionP B McGlave, R J Haake, B C Bostrom, et al.
Blood|September 9, 1999
Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantationE Abruzzese, J E Radford, J S Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2010
Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantationS A Giralt, K F Mangan, R T Maziarz, et al.
Medical and Pediatric Oncology|January 1, 1990
Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell supportD D Hurd, R J Haake, L C Lasky, et al.
The American Journal of Medicine|December 1, 1988
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatmentD D Hurd, T W LeBien, L C Lasky, et al.
Leukemia|March 9, 2007
Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3))I Molnár, N Stark, J Lovato, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|May 7, 1999
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal diseaseJ J Perry, R A Fleming, M V Rocco, et al.
Haematology and Blood Transfusion|January 1, 1985
Chromosome abnormalities in malignant lymphoma: biologic and clinical correlationsC D Bloomfield, D C Arthur, E G Levine, et al.
Genes, Chromosomes & Cancer|March 1, 1990
Sequential karyotypes in non-Hodgkin lymphoma: their nature and significanceE G Levine, S Juneja, D Arthur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host diseaseD J Weisdorf, M E Nesbit, N K Ramsay, et al.
Blood|November 1, 1988
Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remissionP B McGlave, R J Haake, B C Bostrom, et al.
Blood|September 9, 1999
Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantationE Abruzzese, J E Radford, J S Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2010
Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantationS A Giralt, K F Mangan, R T Maziarz, et al.
Medical and Pediatric Oncology|January 1, 1990
Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell supportD D Hurd, R J Haake, L C Lasky, et al.
The American Journal of Medicine|December 1, 1988
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatmentD D Hurd, T W LeBien, L C Lasky, et al.
Leukemia|March 9, 2007
Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3))I Molnár, N Stark, J Lovato, et al.
Pageof 7